Product Details:
Payment & Shipping Terms:
|
| Product Name: | Letrozole/ Femara | Assay: | 98.0-102.0%. USP32 |
|---|---|---|---|
| CAS No.: | 112809-51-5 | MP: | 181-183°C |
| MF: | C17H11N5 | MW: | 285.3 |
| High Light: | epinephrine hydrogen tartrate,raloxifene hydrochloride |
||
Letrozole/ Femara USP/ BP Pharmaceutical Anti-estrogen Powder CAS: 112809-51-5
CAS: 112809-51-5
Assay: 98.0-102.0%. USP32
Packing: 1Kg/foil bag
Delivery: Courier.
MF: C17H11N5
MW: 285.3
Character: White crystalline powder. MP: 181-183°C
Usage: A nonsteroidal aromatase inhibitor structurally related to Fadrozole. Antineoplastic raw materials. For the treatment of breast cancer.
Letrozole (INN, trade name Femara) is an oral non-steroidal aromatase inhibitor for the treatment of hormonally-responsive breast cancer after surgery.
Letrozole is approved by the United States Food and Drug Administration (FDA) for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women.
Hot products:
| oxandrolone |
| Exemestane(Aromasin) |
| GW501516(GSK-516) |
| Dromostanolone propionate |
| citrate |
| Anastrozole |
| Superdrol Powder (methyl-drostanolone) |
| Lidocaine hydrochloride |
| Benzocaine |
| HGH Fragment 176-191 |
| Trenbolone Hexahydrobenzyl Carbonate |
| Boldenone Cypionate |
| Melanotan II Acetate(10mg) |
| LGD-4033 |
| 1,3-DMAA; 1,3-Dimethylamylamine HCl |
| Testosterone sustanon 250mg/ml |
| Boldenone Undecylenate 300mg/ml |
| ipamorelin(2mg) |
| trestolone acetate |
| Stanozolol (Winstrol) |
| Durabolin |
| Stanozolol 50mg/ml (Suspension Oil/injection) |
| IGF-1 LR3 |
| Testosterone isocaproate |
| Letrozole |
| GHRP-6(5mg) |
| Methenolone Acetate |
| Pregabalin |
| Nandrolone decanoate (DECA)250mg/ml |
Key point:
Letrozole/ Femara USP/ BP Pharmaceutical Anti-estrogen Powder CAS: 112809-51-5
